Tuberculosis (TB) remains a significant global health concern, necessitating advancements in detection methods. Modern diagnostic strategies offer a more accurate, rapid, and efficient detection process, thus enhancing TB control and management.
Introduced in 2010, GeneXpert MTB/RIF revolutionized TB diagnostics. It uses real-time polymerase chain reaction (PCR) to detect Mycobacterium tuberculosis complex (MTBC) and rifampicin resistance within two hours. Its high sensitivity and specificity make it an excellent tool for diagnosing TB, especially in HIV co-infected patients and extrapulmonary TB.
Line Probe Assays (LPAs) are WHO-endorsed molecular tests that detect TB and drug resistance. They offer quick results and are particularly useful in diagnosing multi-drug resistant TB (MDR-TB). However, their reliance on cultured samples may limit their utility in resource-poor settings.
Next-Generation Sequencing (NGS) is an emerging technology in TB diagnostics. It provides comprehensive genomic information, allowing for the identification of drug resistance mutations and strain typing. Although currently expensive and technically demanding, NGS promises a future of personalized TB treatment.
Interferon-Gamma Release Assays (IGRAs) are blood tests that measure the immune response to TB antigens. They offer an advantage over traditional tuberculin skin tests by reducing false positives due to BCG vaccination or non-tuberculous mycobacteria.
Advancements in TB detection have significantly improved diagnostic accuracy and speed. However, challenges remain, including cost, technical complexity, and the need for infrastructure and trained personnel. Continued research and innovation are vital to overcoming these barriers and ensuring that these advanced diagnostics are accessible to all who need them.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation